Delivery Order SPE2DB22D3301-SPE2DB25FY5AR
Award Date 5/20/25
Potential Completion Date 6/11/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $37,259.45 on September 3, 2025, for the supply of Jemperli 500 mg/10 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 24, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Jemperli (venetoclax) is a targeted cancer therapy used in the treatment of hematologic malignancies, representing a specialized...
- The Defense Logistics Agency awarded a $37,259.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of JEMPERLI 500 mg/10 mL vials. This non-set-aside competitive award was issued on August 1, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. JEMPERLI is a specialized pharmaceutical product, and this order represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $89,422.68 to AmerisourceBergen Drug Corp for Jemperli (venetoclax) 500 mg/10 mL vials on July 17, 2025, with completion expected by August 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Jemperli (venetoclax) 500 mg/10 mL vials. This $22,355.67 firm fixed-price delivery order carries an ultimate completion date of October 15, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $149,037.80 and a firm fixed price structure. This contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $1 billion vehicle valued through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.8K to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and carries a firm fixed-price structure, with an ultimate completion date of September 23, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Jemperli is a specialized pharmaceutical product used in oncology treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $59,615.12 and firm fixed pricing. This is a competitive award with no set-aside designation, requiring completion by September 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $14,903.78. This is a firm fixed price delivery order under a child contract with no set-aside designation, requiring performance and completion by August 29, 2025. The drug will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,903.78 contract is for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $113,363.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...